Multisystem inflammatory syndrome in children featuring ataxia and papilledema: a case report

Seyed Hesamedin Nabavizadeh1, Rafat Noeiaghdam2, Leila Johari1

  • 1Allergy Research Center, Department of Pediatrics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

PubMed

Insights

Multisystem inflammatory syndrome in children (MIS-C) can present with neurological symptoms. This case highlights concurrent ataxia and papilledema as rare, potentially treatable, signs of MIS-C.

Area of Science:

  • Pediatric Neurology
  • Infectious Diseases
  • Inflammatory Syndromes

Background:

  • Neurological symptoms can occur in children with multisystem inflammatory syndrome (MIS-C).
  • Concurrent ataxia and papilledema have not been previously reported in MIS-C patients.
  • Early recognition of neurological signs is crucial for timely intervention.

Purpose of the Study:

  • To report a rare case of concurrent ataxia and papilledema in a child with MIS-C.
  • To increase awareness of unusual neurological presentations of MIS-C among healthcare providers.

Main Methods:

  • Case report of a 13-year-old boy presenting with MIS-C symptoms.
  • Detailed description of neurological manifestations including ataxia and papilledema.
  • Documentation of treatment response to high-dose methylprednisolone and intravenous immunoglobulin.

Main Results:

  • The patient exhibited fever, rash, vomiting, diarrhea, conjunctivitis, photophobia, headache, and ataxia.
  • Neurological symptoms, including ataxia, showed improvement after treatment.
  • The patient was discharged after 9 days of hospitalization.

Conclusions:

  • Ataxia and papilledema are extremely rare but possible neurological manifestations of MIS-C.
  • Physicians should consider these rare signs in the differential diagnosis of MIS-C.
  • Prompt diagnosis and treatment can lead to favorable outcomes in pediatric patients with MIS-C.
Abstract

Related Concept Videos

Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
199
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
15
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
15
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
22
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
19